Resultado da Busca
15 de mai. de 2024 · Abstract. Colon cancer stem cells are a group of cells in a tumor that can reproduce themselves and change into different types of cells. They are thought to cause tumors to initiate, grow, and become resistant to treatment. Because of this, focusing on the stem cells of colon cancer has become an appealing way to develop new cancer treatments.
15 de mai. de 2024 · This study provides ideas and methods to enhance survival rates in patients with CRC and explores the mechanisms through which MDSCs contribute to the immunosuppressive microenvironment, the current therapeutic approaches and technologies targeting MDSCs, and the therapeutic potential of modulating MDSCs in CRC treatment. Severe immunosuppression is a hallmark of colorectal cancer (CRC ...
Há 17 horas · Esse conteúdo chega a órgãos como cérebro, rins, pele, coração e fígado, podendo amplificar a resposta de alguns quadros. Isso explica por que a microbiota intestinal vem sendo relacionada à exacerbação de problemas como acne, obesidade, rinite alérgica, eczema, candidíase, síndrome do intestino irritável, depressão e ansiedade.
Há 17 horas · Among 2,811 incident colorectal cancer cases, 1,065 of the patients had tissue available for analyzing F nucleatum. The investigators revealed that those who had undergone appendectomy had a 47% lower risk of developing F nucleatum –positive colorectal cancer compared with those who hadn't undergone the procedure.
Há 17 horas · AMA Style. Sur D, Coroama CI, Audisio A, Fazio R, Coroama M, Lungulescu CV. Clinical Outcome of Colorectal Cancer Patients with Concomitant Hypertension: A Systematic Review and Meta-Analysis.
Há 17 horas · DDW：1999-2020年45岁以下人群结直肠癌癌症发病率上升. MONDAY, May 13, 2024 -- For individuals aged younger than 45 years, the incidence of colorectal cancer increased considerably from 1999 to 2020, with a 333 percent increase among those aged 15 to 19 years, according to a study presented at the 2024 Digestive Disease Week ...
Há 8 horas · The study focused on colon cancer as a model system and involved physically screening a large library of approved drugs or small molecules to identify these promising compounds. Tests on animal models, particularly mice, treated with these molecules alongside standard chemotherapy drugs for colon cancer, showed minimal to no tumor progression.
